Molecular structural investigations of quinoxaline derivatives through 3D-QSAR, molecular docking, ADME prediction and pharmacophore modeling studies for the search of novel antimalarial agent
Achal Mishra, Vibhu Jha, Harish Rajak (2022)
Vibhu joined Institute of Cancer Therapeutics as an Assistant Professor in Computational Drug Design. Vibhu utilizes conventional computational modeling tools such as docking, molecular dynamics, virtual screening along with the state-of-the-art Artificial Intelligence and Machine Learning tools to study protein – ligand, protein – protein, protein – DNA interactions, that further helps to develop small molecule inhibitors/modulators against various cancer types.
Vibhu Jha has studied B. Pharm. from Chhattisgarh Swami Vivekananda Technical University (CSVTU), Bhilai, India (2008 – 2012). Vibhu undertook M. S. Pharm. (Medicinal Chemistry) from the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, India (2013 – 2015). As a part of his masters dissertation, he spent one year at the CSIR – Central Drug Research Institute (CDRI), Lucknow, India, working on ‘In silico studies and synthesis of antidiabetic agents.’ Vibhu subsequently joined School of Pharmacy, ITM University, Gwalior, India as an Assistant Professor carrying out teaching and research activities at UG level (2015 – 2017). Vibhu obtained an international fully-funded PhD position at the Department of Pharmacy, University of Pisa, Italy and was awarded ‘Excellent honors' (2017 – 2021). His PhD was focused on molecular modeling and virtual screening studies to identify new anticancer hit compounds, against druggable protein targets. In addition, Vibhu spent 6-months as a visiting PhD researcher at the Institute of Cancer Therapeutics (2019), gaining medicinal chemistry experience.
Vibhu joined
School of Life Sciences, University of Dundee, UK, as a Researcher in Molecular
Modeling, focussing on antitubercular and antimalarial drug discovery (2021 –
2022). Vibhu subsequently moved to the Department of Chemistry and Molecular
Biology, University of Gothenburg, Sweden as a Postdoc (2022 – 2023), working
on various anticancer drug discovery projects driven by the state-of-the-art
computational modeling techniques, also including masters project supervision, and teaching. Vibhu is an active collaborator
with different research groups in Italy, Sweden, Germany and India.
My research involves utilizing a wide range of computational
modeling techniques such as homology modeling, docking, molecular dynamics
simulations, QM/MM simulations and binding free energy calculations to study
protein – ligand and protein – protein interactions, their mechanism of activation/inhibition
relevant to cancer. The research is further supported by structure-based and
ligand-based drug design studies involving high-throughput virtual screening, pharmacophore
and QSAR modeling to develop new hit and lead compounds against cancer drug targets
as following:
(A) Targeting
1C metabolism pathway to develop selective inhibitors of methylenetetrahydrofolate
dehydrogenases (MTHFD2), serine hydroxy methyltransferase 2 (SHMT2) and dihydrofolate
folate reductases (DHFR) against breast and colorectal cancers.
(B) Developing
dual inhibitors of mutated epidermal growth factor receptor tyrosine kinases EGFR
(L858R/T790M)/ACK1 as a new therapeutic strategy to overcome drug resistance in
lung cancers.
3
(C) Developing
inhibitors that simultaneously inhibit human topoisomerases (hTopos) and
histone deacetylases (HDACs), showing dual mode of inhibition against lung
cancer.
Artificial intelligence and machine learning
routines such as random forest (RF), support vector machine (SVM), artificial
neural network (ANN) are furthermore employed to develop predictive and
generative models against (1) ALDH1A1, ALDH1A2, ALDH1A3, ALDH3A1 and ALDH71
isoforms (2) EGFR (L858R/T790M) and ACK1 kinases, using huge chemical databases.
Achal Mishra, Vibhu Jha, Harish Rajak (2022)
Vibhu Jha, Leif A. Eriksson (2023) Drug Repurposing . De Gruyter.
Elisabet Batlle Rocafort; Ali I. Ibrahim; Maria Sadiq; Sneha Smarakan; Vibhu Jha; Tiziano Tuccinardi; Fiona Frame; Norman Maitland; Rafael Jiménez Aguilar; Raquel Pequerul Pavón; Xavier Parés Casampera; Goreti Ribeiro Morais; Jaume Farrés Vicen; Klaus Pors (2022) Proceedings: AACR Annual Meeting.
Vibhu Jha (2018) Joint Event on 8th World Congress on Chemistry and Organic Chemistry & International Conference on Biomedicine & Pharmacotherapy.
Rani P, Chahal S, Ranolia A, Kiran, Kumar D, Kataria R, Kumar P, Singh D, Duhan A, Jha V, Wahajuddin M, Joshi G, Sindhu J. (2025) Rsc Medicinal Chemistry.
Joshi, G., Yadav, U. P., Rafiq, Z., Grewal, P., Kumar, M., Singh, T., Jha, V., Sharma, P., Eriksson, L. A., Srinivas, L., Dahibhate, N. L., Srivastava, P., Bhutani, P., Mishra, U. K., Sharon, A., Banerjee, U. C., Sharma, N., Chatterjee, J., Tikoo, K., Singh, S., Kumar, R. (2025) Journal of Medicinal Chemistry.
Berith F. Pape, Shraddha Parate, Leif A. Eriksson, Vibhu Jha (2025) Biochemistry.
Jain, N. K., Chandrasekaran, B., Khazaleh, N., Jain, H. K., Lal, M., Joshi, G., & Jha, V. (2025) Pharmaceuticals.
Serre, A.R.E;Jha, V.;Rivault, A.;Eriksson, L.A.;Ribeiro Morais, G.;Falconer, R.A. (2024) Organic and Biomolecular Chemistry. 22
Dr.Kapil Kumar Goel;Sandhya Chahal;Devendra Kumar;Dr Shivani Jaiswal;Nidhi Nainwal;Rahul Singh;Shriya Mahajan;Pramod Rawat;Savita Yadav;Prachi Fartyal;Gazanfar Ahmad;Vibhu Jha;ashish ranjan dwivedi (2024) Rsc Medicinal Chemistry.
Shruti Bharadwaj;Kumari Deepika;Asim Kumar;Shivani Jaiswal;Shaweta Miglani;Damini Singh;Prachi Fartyal;Roshan Kumar;Shareen Singh;Mahendra Pratap Singh;Abhay M. Gaidhane;Bhupinder Kumar;Vibhu Jha (2024) Chemical Biology and Drug Design.
Vibhu Jha;Leif A. Eriksson (2024) Scientific Reports.
Jha V;Holmelin FL;Eriksson LA; (2023) Acs Omega. 8
Jha V;Eriksson LA; (2023) ChemistryOpen. 12
Ibrahim AIM;Abul-Futouh H;Bourghli LMS;Abu-Sini M;Sunoqrot S;Ikhmais B;Jha V;Sarayrah Q;Abulebdah DH;Ismail WH; (2022) Current Issues in Molecular Biology. 44
Ali I M Ibrahim, Elisabet Batlle, Smarakan Sneha, Rafael Jiménez, Raquel Pequerul, Xavier Parés, Till Rüngeler, Vibhu Jha, Tiziano Tuccinardi, Maria Sadiq, Fiona Frame, Norman J Maitland, Jaume Farrés, Klaus Pors (2022) Journal of Medicinal Chemistry. 65
Jha V;Galati S;Volpi V;Ciccone L;Minutolo F;Rizzolio F;Granchi C;Poli G;Tuccinardi T; (2021) Journal of Biomolecular Structure and Dynamics. 39
Ibrahim AIM;Ikhmais B;Batlle E;AbuHarb WK;Jha V;Jaradat KT;Jiménez R;Pequerul R;Parés X;Farrés J;Pors K; (2021) Molecules. 26
Jha V;Biagi M;Spinelli V;Di Stefano M;Macchia M;Minutolo F;Granchi C;Poli G;Tuccinardi T; (2020) Molecules. 26
Jha V;Macchia M;Tuccinardi T;Poli G; (2020) Cancers. 12
Poli G;Lapillo M;Jha V;Mouawad N;Caligiuri I;Macchia M;Minutolo F;Rizzolio F;Tuccinardi T;Granchi C; (2019) Journal of Enzyme Inhibition and Medicinal Chemistry. 34
(2019) International Journal of Research in Ayurveda and Pharmacy.
Poli G;Jha V;Martinelli A;Supuran CT;Tuccinardi T; (2018) International Journal of Molecular Sciences. 19
(2018) Asian Journal of Biomedical and Pharmaceutical Sciences.
(2018) Journal of Molecular Structure.